mainsat 14 miller balloon assisted angioplasty in avf maturation … · 2018. 4. 1. · 2009...

7
2/29/2012 1 Gregg A Miller, MD Balloon Assisted Angioplasty in AVF Maturation: CHIEF MEDICAL OFFICER Fresenius Vascular Care ASSISTANT CLINICAL PROFESSOR Columbia University Physicians & Surgeons DISCLOSURE Gregg A Miller, MD Chief Medical Officer Fresenius Vascular Care I have no financial relationships to disclose. www.GreggMillerMD.com 2009 Medicare $491 billion 3.1% from 2008 2009 TOTAL MEDICARE COSTS ESRD (5.9%) $29 billion 11% non-ESRD (94.1%) US Renal Data System: USRDS 2009 Annual Data Report. Bethesda, MD: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009 ANNUAL COST PER PATIENT Based on 2007 ESRD data: $75,344 ($6278.66/mo) for Catheter $72,729 ($6060.75/mo) for AVG $55,112 ($4592.66/mo) for AVF Miller GA et al: Percutaneous salvage of thrombosed immature arteriovenous fistulas. Semin Dial. 2011;24(1): 107-114 AVF v AVG Lee T, et al: Comparison of survival of upper arm arteriovenous fistulas and grafts after failed forearm fistula. J Am Soc Nephrol. 2007;18(6):1936-41

Upload: others

Post on 19-Feb-2021

3 views

Category:

Documents


0 download

TRANSCRIPT

  • 2/29/2012

    1

    Gregg A Miller, MD

    Balloon Assisted Angioplasty in AVF Maturation:

    CHIEF MEDICAL OFFICER

    Fresenius Vascular Care

    ASSISTANT CLINICAL PROFESSOR

    Columbia University Physicians & Surgeons

    DISCLOSURE

    Gregg A Miller, MDChief Medical OfficerFresenius Vascular Care

    I have no financial relationships to disclose.

    www.GreggMillerMD.com

    2009 Medicare $491 billion• 3.1% from 2008

    2009 TOTAL MEDICARE COSTS

    ESRD (5.9%)• $29 billion• 11%

    non-ESRD (94.1%)

    US Renal Data System: USRDS 2009 Annual Data Report. Bethesda, MD: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009

    ANNUAL COST PER PATIENT

    Based on 2007 ESRD data:

    • $75,344 ($6278.66/mo) for Catheter

    • $72,729 ($6060.75/mo) for AVG

    • $55,112 ($4592.66/mo) for AVF

    Miller GA et al: Percutaneous salvage of thrombosed immature arteriovenousfistulas. Semin Dial. 2011;24(1): 107-114

    AVF v AVG

    Lee T, et al: Comparison of survival of upper arm arteriovenous fistulas and grafts after failed forearm fistula. J Am Soc Nephrol. 2007;18(6):1936-41

  • 2/29/2012

    2

    AVF Creation

    AVF SUCCESS RATES

    Unassisted Maturation

    (40%)

    Assisted Maturation;Requires Intervention

    (60%)

    Dember LM et al: Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA. 2008;299(18):2164-2171

    Assisted Maturation

    of AVF

    AVF COMPARISONS

    Mature AVF (unassisted)

    Catheter

    AVG

    Peritoneal Dialysis

    VS

    FISTULA : PRO vs CON

    Less cost PPPY -

    Low infection rate -

    - time to reach clinical success results

    in prolonged catheter time

    - Variable depth � More infiltrations

    PRO vs CONUNASSISTED Maturation vs AVG

    FISTULA MATURATION: PRO vs CON

    AVF prevalence -

    Less cost PPPY -

    Low infection rate -

    - time to reach clinical success results

    in prolonged catheter time

    - Variable depth � more infiltrations

    - Requires multiple visits

    - More procedures / PPY

    - adv procedure skill & equip

    PRO vs CONAssisted Maturation vs AVG

  • 2/29/2012

    3

    TECHNIQUES

    1) Flow Rerouting with Elimination of Competing Branch Veins

    2) Staged Sequential Dilation

    3) Long Length Balloon PTA

    4) Limited Controlled Extravasation

    Directional Guidance Rotate Guiding Catheter

    Step 1: Find the Anastamosis

    THROMBECTOMY MATURATION

    Wire Guided Selective Catheterization

    Step 2: Wire Guided Flow Re-routing

    Demonstrate Basilic Vein Pathway

    using 0.018 Guiding Catheter

    THROMBECTOMY MATURATION

    Find Point of Greatest Stenosis

    Step 3: Confirm Basilic Outflow Vein

    Confirm Lumen

    THROMBECTOMY MATURATION

    Step 4: Dilate in 1mm Increments until 6mm using Long Length Balloons

    THROMBECTOMY MATURATION

    Step 5: Retrograde Access Using Balloon Puncture Technique

    Dilate Inflow Stenosis Fully Efface all Stenoses & Restore Flow

    THROMBECTOMY MATURATION

  • 2/29/2012

    4

    Step 6: Restore Flow / Troubleshoot

    Forearm Flow-

    Check for Perforations

    Upper Arm Flow-

    Check for Unimpeded Drainage

    THROMBECTOMY MATURATION

    Step 7: Eliminate Problematic Collateral Veins

    Antegrade

    Collaterals

    Retrograde

    Collaterals

    THROMBECTOMY MATURATION

    Step 8: Dilate Using Inflow Control

    • Manual Pressure at anastamosis

    • Protect torn distal vein segments

    • Avoid exposing injured distal segments to high arterial pressure

    THROMBECTOMY MATURATION

    Step 9: Final Inspection

    THROMBECTOMY MATURATION

    Second Ballooning

    BEFORE AFTER

    THROMBECTOMY MATURATION

    Follow-Up at Two Weeks

    THROMBECTOMY MATURATION

  • 2/29/2012

    5

    THROMBECTOMY MATURATION

    Follow-Up at Four Weeks

    THROMBECTOMY MATURATION

    Aggressive Approach to Salvage Non-Maturing AVF: A Retrospective Study with F/U (n=122)

    All unusable AVFs underwent salvage procedures

    BAM on AVF DIAMETER

    Miller GA et al: Aggressive approach to salvage non-maturing arteriovenous fistulae: a retrospective study with follow-up. J Vasc Access. 2009;10:183-191

    % PATENT

    Aggressive Approach to Salvage Non-Maturing AVF: A Retrospective Study with F/U (n=122)

    Ave Access intvnt/yr= 1.5

    Miller GA et al: Aggressive approach to salvage non-maturing arteriovenous fistulae: a retrospective study with follow-up. J Vasc Access. 2009;10:183-191

    SECONDARY PATENCY

    Kaplan-Meier Survival Analysis (n=122)

    (mos)

    INTERVENTIONS TO MATURATE

    Lee T, et al: Decreased cumulative access survival in arteriovenous fistulas requiring interventions to promote maturation. Clin J Am Soc Nephrol. 2011;6(3):575-81

  • 2/29/2012

    6

    VASCULAR REMODELING v VESSEL WALL THICKENING

    Lee T, Roy-Chaudhury P: Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis. Chronic Kidney Dis. 200;16(5):329-38

    VASCULAR REMODELING v VESSEL WALL THICKENING

    Lee T, Roy-Chaudhury P: Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis. Chronic Kidney Dis. 200;16(5):329-38

    HOW DO YOU PREDICT?

    HOW DO YOU PREDICT?

    Blood PressureTissue Integrity

    First Failure Predicts Subsequent Failure

    RADIAL ARTERY ANGIOPLASTY

    Turmel-Rodrigues L et al: Percutaneous dilation of the radial artery in nonmaturing autogenousradial-cephalic fistulas for haemodialysis. Nephrol Dial Transplant2009; 24(12): 3782-3788

    PREEMPTIVE PTA

    Preemptive PTA allows for suboptimal veins

    De Marco Garcia LP et al: Primary balloon angioplasty plus balloon agioplasty maturation to upgrade small-caliber veins (

  • 2/29/2012

    7

    SALVAGE FROM SALVAGE PROCEDURE

    Table 3: Follow-up Stats for 108 Matured Fistulas

    Miller GA et al: Percutaneous salvage of thrombosed immature arteriovenousfistulas. Semin Dial. 2011;24(1): 107-114

    IMMATURE FISTULA INTERVENTIONS

    Miller GA et al: Percutaneous salvage of thrombosed immature arteriovenousfistulas. Semin Dial. 2011;24(1): 107-

    114

    Miller GA et al: Aggressive approach to salvage non-maturing arteriovenous fistulae: a retrospective study with follow-up. J VascAccess. 2009;10:183-191

    AVF

    AVF SUCCESS RATES

    Success (40%)

    Failure (60%)

    BAM (93%)

    New Access (7%)

    2.78 intvnt PPPY

    0.06-0.57 intvnt PPPY

    0-4.5% infections/yr

    0.52% infections/yr

    AVF/AVG COST COMPARISON

    Success (40%)

    Failure (60%)

    2.78 intvnt PPPY

    AVG

    AVF

    1.8-5.3 intvnt PPPY$72,729/yr

    $55,112/yr

    0.06-0.57 intvnt PPPY

    0-4.5% infections/yr

    0.52% infections/yr

    6-22% infections/yr

    +$5,487 (maintain)

    =$60,599/yr

    CONCLUSIONS

    Though immature AVF requires more skill, initial procedures, and time….

    •Less infections

    •Fewer interventions

    •Costs less overall

    Assisted Maturation AVF AVG>www.GreggMillerMD.com